This Funding Opportunity Announcement (FOA) invites applications for Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (hereafter termed "Fragile X Centers").
In recognition of the rapidly evolving landscape of FMR1-associated research, NIH recently published a new Strategic Plan for Research on FMR1-Associated Conditions. This Strategic Plan, which was developed in collaboration with many members of the Fragile X community, articulates NIH’s current research priorities, which are directed toward an overarching vision of accelerating the development of effective interventions to prevent or treat FMR1-associated conditions. Successful Fragile X Centers will be composed of multidisciplinary teams of basic, translational and clinical investigators collaborating to address complex, difficult-to-solve problems within specific research priorities identified in the Strategic Plan.
Deadlines:
RFA-HD-20-003 Expiration Date April 4, 2020
Center PD(s)/PI(s) cannot serve as the Lead of a core or research project on another active Fragile X Center.
Applicants may request up to $1.3 million in direct costs per year (excluding subaward F&A costs).
The scope of the proposed project should determine the project period. The maximum project period is 5 years.
